Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Stomach Cancer
Interventions
DRUG

Docetaxel, Capecitabine and Oxaliplatin

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT00446290 - Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer | Biotech Hunter | Biotech Hunter